. Lobe-specific pattern of STAT5 deletion in 6 month-old △STAT5 mice. A. Lobe-specific expression of STAT5A and STAT5B mRNA in STAT5 f/f and △STAT5 mice as determined by RT-qPCR. B-C. Lobe-specific expression of STAT5 protein in STAT5 f/f and △STAT5 mice as determined by immunoblot (each lane corresponds to a different animal). Quantification of STAT5 expression (STAT5/ACTIN) was performed by densitometry (C). D. Immunohistochemical analysis of STAT5 expression in anterior (AP), dorsal (DP), lateral (LP) and ventral (VP) prostates of STAT5 f/f and △STAT5 mice, as indicated. Statistics: Stars denote significant differences in a repeated-measures two-way ANOVA with Sidak's multiple comparisons. Size bars: 250 µm in large images and 50 µm in insets.
. Lobe-specific pattern of STAT5 deletion in 6 month-old △STAT5 mice. A. Lobe-specific expression of STAT5A and STAT5B mRNA in STAT5 f/f and △STAT5 mice as determined by RT-qPCR. B-C. Lobe-specific expression of STAT5 protein in STAT5 f/f and △STAT5 mice as determined by immunoblot (each lane corresponds to a different animal). Quantification of STAT5 expression (STAT5/ACTIN) was performed by densitometry (C). D. Immunohistochemical analysis of STAT5 expression in anterior (AP), dorsal (DP), lateral (LP) and ventral (VP) prostates of STAT5 f/f and △STAT5 mice, as indicated. Statistics: Stars denote significant differences in a repeated-measures two-way ANOVA with Sidak's multiple comparisons. Size bars: 250 µm in large images and 50 µm in insets. * p < 0.05; **** p < 0.0001. Figure S2 . STAT5 deletion has no detectable effect on the prostate tissue. A. The prostate weight in 6, 12 and 18 month-old STAT5 f/f and ΔSTAT5 mice is expressed as the ratio of total prostate normalized to the weight of corresponding animal. There was no genotype-dependent difference between age-matched mice. B. Histological analysis (hematoxylin counterstaining) of the four prostate lobes from 6 month-old STAT5 f/f and △STAT5 mice showing no obvious sign of abnormalities. Size bars: 250 µm in large images and 50 µm in insets. and PRLR (D) was monitored in dorsal prostates of 6 month-old STAT5 f/f , Pb-PRL STAT5f/f and Pb-PRL ΔSTAT5 using RT-qPCR. Statistics: Stars denote significant differences in a repeated-measures one-way ANOVA with Tukey's multiple comparisons (C) or two-way ANOVA with Sidak's multiple comparisons (D). Size bars: 250 µm in large images and 50 µm in insets. Size bars: 250 µm in large images and 50 µm in insets. * p < 0.05, ** p <0.01, *** p < 0.001, **** p < 0.0001. Figure S4 . Lobe-specific effects of STAT5 deletion of 6 month-old Pb-PRL ΔSTAT5 mice (complementary to Figure 4) . A. The weight of lateral (LP) and ventral (VP) prostate lobes in 6 month-old STAT5 f/f , Pb-PRL STAT5f/f and Pb-PRL ΔSTAT5 mice is expressed as the ratio of lobe weight normalized to the weight of corresponding animal. B. The proliferation index of lateral and ventral prostate was determined in the three genotypes (see Figure 4 for details). C. Histological analysis (hematoxylin counterstaining) of lateral and ventral lobes of Pb-PRL STAT5f/f and Pb-PRL ΔSTAT5 mice showing similar hyperplasia in both genotypes. D. Inflammation was identified using CD45 immunostaining. The degree of inflammation was quantified using Calopix software and is represented as the ratio of CD45+ area versus stroma area. E,F. Expression of rat PRL transgene was monitored using immunoblot (D) and RT-qPCR (E) in the three genotypes. Stars denote significant differences in a repeated-measures one-way ANOVA with Tukey's multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Figure 5) . A. The prostate weight in 6, 12 and 18 month-old STAT5 f/f , Pb-PRL STAT5f/f and Pb-PRL ΔSTAT5 mice is expressed as the ratio of total prostate weight normalized to the weight of corresponding animal. Symbols: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 (versus STAT5 f/f ); # p < 0.05, ## p < 0.01, ### p < 0.001, #### p < 0.0001 (versus Pb-PRL △STAT5 ). B. Histological analysis (hematoxylin counterstaining) of the anterior (AP), dorsal (DP) and ventral (VP) prostate lobes from 12 month-old Pb-PRL STAT5f/f and Pb-PRL ΔSTAT5 mice showing similar abnormalities including PINs, increased stromal density (stars), inflammation (arrows) and dense eosinophilic secretions (S). Statistics: Symbols (*: vs age-matched STAT5 f/f ; #: versus age-matched Pb-PRL
△STAT5
) denote significant differences in a repeated-measures two-way ANOVA with Tukey's multiple comparisons. Size bars: 250 µm in large images and 50 µm in insets. Figure S6 . Characterization of PRLR and AR signaling pathways in dorsal prostate of 12 month-old STAT5 f/f , Pb-PRL STAT5f/f and Pb-PRL △STAT5 mice (complementary to Figure 6) . A. The expression of various actors of the PRLR pathway as determined by RT-qPCR was analyzed in dorsal prostates of 12 month-old STAT5 f/f , Pb-PRL STAT5f/f and Pb-PRL △STAT5 mice. B. The expression of AR and of target genes of the AR pathway as determined by RT-qPCR was analyzed in dorsal prostates of 6 and 12 month-old STAT5 f/f , Pb-PRL STAT5f/f and Pb-PRL △STAT5 mice, as indicated. In both panels data are expressed as fold-induction versus STAT5 f/f samples. Statistics: Stars denote significant differences in a repeated-measures one-way ANOVA with Tukey's multiple comparisons. Except for PRLR (per isoform), stars denote significant differences in a repeated-measures two-way ANOVA with Tukey's multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. * maps amino acids 750-779 that are common to both STAT5 isoforms. 
